M. van der Valk

Latest

• A randomized trial to study first-line combination therapy with or without a protease inhibitor in HIV-1-infected patients
• Highly active antiretroviral therapy-induced lipodystrophy has minor effects on human immunodeficiency virus-induced changes in lipolysis, but normalizes resting energy expenditure
• Nevirapine-containing antiretroviral therapy in HIV-1 infected patients results in an anti-atherogenic lipid profile